BRIDGEBIO PHARMA INC - COM (BRDS)

CUSIP: 09077J107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
157,901,493
Share change
+9,321,404
Total reported value
$28,447,930
Put/Call ratio
1.1%
Price per share
$0.18
Number of holders
70
Value change
+$1,059,192
Number of buys
33
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 09077J107?
CUSIP 09077J107 identifies BRDS - BRIDGEBIO PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BRIDGEBIO PHARMA INC - COM (BRDS) as of Q4 2022

As of 31 Dec 2022, BRIDGEBIO PHARMA INC - COM (BRDS) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 157,901,493 shares. The largest 10 holders included FMR LLC, Sacks David O, Valor Management LLC, SC US (TTGP), LTD., G.F.W. Energy XII, L.P., BlackRock Inc., VANGUARD GROUP INC, Accel Growth Fund IV Associates L.L.C., Upfront Ventures Management, LLC, and CAISSE DE DEPOT ET PLACEMENT DU QUEBEC. This page lists 70 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.